Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Praschak-Rieder

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Psychiatry|December 31, 1997
Severe atypical symptoms without depression in SAD: effects of bright light therapyE Ibatoullina, N Praschak-Rieder, S Kasper
Drug Safety|November 14, 1997
A risk-benefit assessment of mirtazapine in the treatment of depressionS Kasper, N Praschak-Rieder, J Tauscher, et al.
The International Journal of Neuropsychopharmacology|August 2, 2003
Quetiapine in a delusional depressed elderly patient: no EPS and a favourable outcomeI Leitner, N Praschak-Rieder, M Willeit, et al.
Wiener Klinische Wochenschrift|November 17, 1998
[Mirtazapine in inpatient treatment of depressed patients]U Bailer, N Praschak-Rieder, L Pezawas, et al.
Wiener Medizinische Wochenschrift (1946)|January 19, 2000
[Therapeutic sleep deprivation and phototherapy]N Praschak-Rieder, M Willeit, A Neumeister, et al.
Advances in Experimental Medicine and Biology|March 18, 2000
Monoamine depletion in non-pharmacological treatments for depressionA Neumeister, N Praschak-Rieder, M Willeit, et al.
International Clinical Psychopharmacology|October 21, 1999
Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder?A Neumeister, A Habeler, N Praschak-Rieder, et al.
Der Nervenarzt|July 1, 1997
[The tryptophan depletion test. Basic principles and clinical relevance]A Neumeister, N Praschak-Rieder, B Hesselmann, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 28, 2001
Reboxetine in seasonal affective disorder: an open trialE Hilger, M Willeit, N Praschak-Rieder, et al.
Pharmacopsychiatry|March 1, 2007
Escitalopram in seasonal affective disorder: results of an open trialE Pjrek, D Winkler, J Stastny, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Psychiatry|December 31, 1997
Severe atypical symptoms without depression in SAD: effects of bright light therapyE Ibatoullina, N Praschak-Rieder, S Kasper
Drug Safety|November 14, 1997
A risk-benefit assessment of mirtazapine in the treatment of depressionS Kasper, N Praschak-Rieder, J Tauscher, et al.
The International Journal of Neuropsychopharmacology|August 2, 2003
Quetiapine in a delusional depressed elderly patient: no EPS and a favourable outcomeI Leitner, N Praschak-Rieder, M Willeit, et al.
Wiener Klinische Wochenschrift|November 17, 1998
[Mirtazapine in inpatient treatment of depressed patients]U Bailer, N Praschak-Rieder, L Pezawas, et al.
Wiener Medizinische Wochenschrift (1946)|January 19, 2000
[Therapeutic sleep deprivation and phototherapy]N Praschak-Rieder, M Willeit, A Neumeister, et al.
Advances in Experimental Medicine and Biology|March 18, 2000
Monoamine depletion in non-pharmacological treatments for depressionA Neumeister, N Praschak-Rieder, M Willeit, et al.
International Clinical Psychopharmacology|October 21, 1999
Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder?A Neumeister, A Habeler, N Praschak-Rieder, et al.
Der Nervenarzt|July 1, 1997
[The tryptophan depletion test. Basic principles and clinical relevance]A Neumeister, N Praschak-Rieder, B Hesselmann, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 28, 2001
Reboxetine in seasonal affective disorder: an open trialE Hilger, M Willeit, N Praschak-Rieder, et al.
Pharmacopsychiatry|March 1, 2007
Escitalopram in seasonal affective disorder: results of an open trialE Pjrek, D Winkler, J Stastny, et al.
Pageof 4